Jackson, Adam https://orcid.org/0000-0002-3674-3960
Blakes, Alexander J. M. https://orcid.org/0000-0002-0260-7020
Alhaddad, Bader
Henry, Olivia J. https://orcid.org/0000-0002-4717-8346
Delgado-Vega, Angelica M. https://orcid.org/0000-0002-9865-0591
Wall, Elizabeth
Abdelhadi, Ola
Agrawal, Shakti
Bakur, Khadijah
Blair, Edward
Brady, Angela F.
Brittain, Helen
Chandler, Kate E.
Clarke, Natasha
Danelli, Miriana
Drinkall, Nicholas
Duba, Irene https://orcid.org/0009-0005-4189-8704
Elmslie, Frances https://orcid.org/0000-0002-2508-9107
Ellingford, Jamie https://orcid.org/0000-0003-1137-9768
Ewans, Lisa J.
Fennell, Andrew P. https://orcid.org/0000-0001-6744-1810
Gazdagh, Gabriella
Heller, Simon P. https://orcid.org/0000-0001-7335-9266
Hammarsjö, Anna
Karrman, Kristina
Kini, Usha
Lesko, Nicole
Lindstrand, Anna
Macintosh, Rebecca https://orcid.org/0000-0001-5036-0264
Mansour, Sahar
Menzies, Lara
Metcalfe, Kay
Milhench, Alison
Nashef, Lina
O’Keefe, Raymond T. https://orcid.org/0000-0001-8764-1289
Pacheco, Nadja Pekkola
Palmer, Elizabeth E. https://orcid.org/0000-0003-1844-215X
Parida, Amitav
Prescott, Katrina
Redman, Melody
Renieri, Alessandra https://orcid.org/0000-0002-0846-9220
Fallerini, Chiara
Rizzo, Caterina Lo
Sachdev, Rani
Simons, Cas https://orcid.org/0000-0003-3147-8042
Sisodiya, Sanjay M. https://orcid.org/0000-0002-1511-5893
Stewart, Helen
Stödberg, Tommy
Banos-Pinero, Benito
Taylan, Fulya https://orcid.org/0000-0002-2907-0235
Thomas, Huw B. https://orcid.org/0000-0001-9626-9706
Tinella, Flavia
Wiafe, Samuel
Wedell, Anna
Whiffin, Nicola
Walker, Susan https://orcid.org/0000-0002-5016-6426
Rius, Rocio https://orcid.org/0000-0002-9871-3126
Chae, Jong Hee
Nordgren, Ann https://orcid.org/0000-0003-3285-4281
Alkuraya, Fowzan https://orcid.org/0000-0003-4158-341X
Lord, Jenny https://orcid.org/0000-0002-0539-9343
Banka, Siddharth https://orcid.org/0000-0002-8527-2210
Article History
Received: 2 September 2025
Accepted: 23 February 2026
First Online: 30 March 2026
Competing interests
: L.M. has received personal consultancy fees from Mendelian, a rare disease digital health company, outside of the submitted work. N.W. has received research grant funding from Novo Nordisk and BioMarin Pharmaceutical. All other authors declare no competing interests.